Trazodone for Adolescents (12 to 17): School and Activity Considerations
A clinician-reviewed guide to how trazodone affects school performance, sleep schedules, physical activity, and daily functioning in teenagers aged 12 to 17.
Age V2 Trazodone
14 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
14articles
3topic areas covered
Jul 14, 2025latest review
Age V2 Trazodone library
Showing 14 of 14 clinical reviews.
Trazodone for Adolescents Ages 12 to 17: Caregiver Administration Guidance
A complete caregiver guide to trazodone dosing, administration timing, safety monitoring, and drug interactions for adolescents aged 12 to 17, reviewed by the HealthRX medical team.
Trazodone for Children Under 12: Caregiver Administration Guidance
A detailed caregiver guide to administering trazodone in children under 12, covering dosing, timing, formulation, side effects, and when to call the prescriber. Reviewed by the HealthRX medical team.
Trazodone Geriatric (65+): Caregiver Administration Guidance
A complete caregiver guide to giving trazodone safely to adults aged 65 and older, covering dosing, fall risk, drug interactions, and when to call a prescriber.
Trazodone in Adolescents (Ages 12 to 17): Developmental Impact, Risks, and Clinical Guidance
A comprehensive clinical review of trazodone's effects on adolescent brain development, sleep architecture, mood, and growth, with dosing guidance, safety data, and answers to common questions for patients aged 12 to 17.
Trazodone in Adolescents (Ages 12 to 17): Off-Label Use, Evidence, Dosing, and Risks
A clinical review of off-label trazodone use in adolescents aged 12 to 17, covering the evidence base, dosing guidance, safety concerns including the black-box warning, and when to consider alternatives.
Trazodone in Adolescents (Ages 12 to 17): Transitioning to Adult Care
A clinician-facing guide to managing trazodone therapy in adolescents aged 12 to 17 as they transition to adult psychiatric and primary care, covering dosing, black-box warnings, monitoring, and handoff strategies.
Trazodone in Adults 65 and Older: Off-Label Uses, Doses, and Safety
A clinician-reviewed guide to off-label trazodone use in geriatric patients, covering insomnia, agitation in dementia, dosing adjustments, drug interactions, and current guideline positions.
Trazodone in Adults 65 and Older: School, Work, and Daily Activity Considerations
A clinician-reviewed guide to trazodone use in geriatric patients aged 65 and older, covering cognitive effects, fall risk, driving safety, social engagement, and how to adjust daily activities around dosing schedules.
Trazodone in Children Under 12: Developmental Impact, Safety, and Clinical Considerations
A clinically detailed review of trazodone's developmental impact in pediatric patients under age 12, covering neurodevelopmental risks, off-label use evidence, dosing caution, and current prescribing guidance.
Trazodone in Children Under 12: School and Activity Considerations
A clinician-reviewed guide to how trazodone affects school performance, physical activity, and daily functioning in children under 12, including dosing context, sedation management, and teacher communication strategies.
Trazodone in Children Under 12: What Families Need to Know About Transitioning to Adult Care
A clinician-reviewed guide covering trazodone use in pediatric patients under age 12, the evidence base, safety considerations, and how to manage the transition to adult psychiatric care.
Trazodone in Children Under 12: What Parents and Clinicians Need to Know About Off-Label Use
A clinical review of off-label trazodone use in pediatric patients under age 12, covering evidence, dosing considerations, safety signals, and guideline positions.
Trazodone in Geriatric Patients (65+): Transition to Adult Care Guide
A clinician-facing guide on trazodone use in adults 65 and older moving from pediatric or young-adult care settings, covering dosing, fall risk, drug interactions, and safe deprescribing.